Results 251 to 260 of about 300,540 (308)

Epitope-based vaccine of NiV targeting glycoprotein and fusion protein: an integrated immunoinformatics and bioinformatics approach. [PDF]

Virus Res
Aggad WS, Mishra SK, Alqahtani T, Guendouzi A, Tóth Z, Zaki MEA.   +5 more
europepmc   +1 more source

Cross-Reactivity of Antiphospholipid Antibodies with Gut Commensal Proteins in Antiphospholipid Syndrome. [PDF]

TH Open
van Mourik DJM, Balvers M, Jansen VLBI, de Jonge PA, Coppens M, Nieuwdorp M, Middeldorp S, Eikenboom JCJ, Voorberg J, van Mens TE.   +9 more
europepmc   +1 more source

Comparing CD8+ T cell ENV epitopes of two HLA class I alleles associated with different outcomes of HIV-1 infection with broadly neutralizing antibodies epitope targets discovered to date. [PDF]

Front Immunol
Ramdoyal A, Daniuk CA, Omange RW, Kimani J, Luo M.   +4 more
europepmc   +1 more source

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells. [PDF]

Proc Natl Acad Sci U S A
Mishra A, Abelman RO, Cunneely Q, Putaturo V, Deshpande AA, Bell R, Seider EM, Xu KH, Shan M, Kelly J, Huang SB, Rieur O, Knape J, Gopinathan KA, Kikkeri K, Edd JF, Walsh J, Dai CS, Ellisen LW, Ting DT, Nieman L, Toner M, Bardia A, Haber DA, Maheswaran S.   +24 more
europepmc   +1 more source

RETRACTION: Mechanism of p27 Upregulation Induced by Downregulation of Cathepsin B and Upar in Glioma

Molecular Oncology, EarlyView.
RETRACTION: S. Gopinath, K. Alapati, R. R. Malla, C. S. Gondi, S. Mohanam, D. H. Dinh, and J. S. Rao, “Mechanism of p27 Upregulation Induced by Downregulation of Cathepsin B and Upar in Glioma,” Molecular Oncology 5, no. 5 (2011): 426–437, https://doi.org/10.1016/j.molonc.2011.07.004.
wiley   +1 more source

Design and preparation of multi-epitope mRMA vaccine for Brucella VirB8, OMO25 and other proteins

Wu H, Sai N, Guo J, Yang W, Shen Z, Shen X, Dong Z, Bao L.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hypervariable epitope constructs as a means of accounting for epitope variability

Vaccine, 1994
Epitope variability is one of the greatest obstacles to development of synthetic peptide vaccines. Based on a recently described hypervariable epitope (aa 414-434) on the envelope glycoprotein (gp130) to simian immunodeficiency virus (SIVmac142), we have developed a novel approach to account for epitope variability.
David E Anderson, A Malley, Eli Benjamini   +2 more
exaly   +3 more sources

Epitope Mapping

2003
An epitope is defined as the site on an antigen at which an antibody binds. In the case of proteins the epitopes can be classified as continuous (or sequential) and discontinuous according to whether or not the amino acids recognized are close together in the primary sequence or are well-separated but brought together by the folding of the protein. The
J E, Heckels, M, Christodoulides
openaire   +4 more sources

Epitope mapping

Immunology Today, 1991
The immune response to extrinsic and intrinsic antigens involves specific antigen receptors on T and B cells. The precise antigenic determinants, or epitopes, recognized by these receptors are discrete sequences within the native antigen. The ability to identify and manufacture key epitopes in the immune response has important implications for disease ...
A C, Horsfall, F C, Hay, A J, Soltys, M G, Jones   +3 more
openaire   +2 more sources